Origo Cosmeceuticals : Leveraging Industry Expertise to Revolutionize the Indian Cosmeceutical Sector

Mansur Khan, Managing Director

Mansur Khan

Managing Director

Considered 4th largest beauty market in the world, India has a vibrant cosmetics sector. While numerous international cosmetics brands are leveraging their global exposure and expertise to dominate the market, native brands are leaving no stone unturned to expand their client base. There has been a significant shift towards natural and organic skincare products, with Indian customers preferring Indian ayurvedic and herbal cosmetic brands over harmful chemical-based products. Even various initiatives by the government of India have encouraged domestic manufacturing and promoting local products, fostering an environment where Indian cosmetics brands can thrive. Among the leading cosmetics brands in the country, one firm that stands out in innovation, extensive R&D, and superior product quality is Origo Cosmeceuticals.

Led by Mansur Khan, Origo Cosmeceuticals is a Bengaluru-based leading dermatology and cosmetics organization specializing in sourcing and supplying a wide range of potent and result-oriented effective Herbal cosmeceuticals products, including supplements, cosmetics, cleansing products, skincare products, haircare products, body care products, and many more. With a strong focus on ethical sourcing and environmental responsibility, the firm is committed to building a brand that prioritizes integrity, innovation, and sustainability, reflecting its belief in harnessing the power of nature.

Pioneers of The Indian Cosmeceutical Sector

What makes Origo stand out from the rest of its peers in the market is the absolute innovation and comprehensive R&D that has gone into curating those cosmetic products. A qualified pharmacist with a Bachelor of Pharmacy degree from Visvespura Institute of Pharma Sciences, Mansur has over 30 years of extensive experience in marketing and manufacturing cosmeceuticals products across India and abroad. He has been the key force behind the firm's constant effort to introduce innovative and highly efficienting redient s across India. Origo was the first company in India to introduce Palmetto extract for hair loss treatment. Mansur was also the first to introduce Glutathione, a vastly used antioxidant, in India in 2008.

Apart from that, the firm also introduced various highly effective ingredients, such as sheep placenta extract, emu oil, synthetic snake venom, alpha arbutin, and many more, in the Indian market. “Origo is well known for offering a unique range of original natural cosmetics. We strongly believe in ingredient transparency and customization”, adds Mansur. “Our strong focus on R&D as well as clinical backing is a demonstration of the safety and effectiveness of our products. We also organize a lot of camps on skin awareness across the rural areas of the country to make people aware of the importance of good skincare”.

With a focus on herbal bioactive ingredients, Origo’s dedication to ethical sourcing and environmental responsibility guides every aspect of the firm’s operations

Mansur Khan, Managing Director

A Strong Emphasis on Natural Ingredients

Another major USP of Origo is its strong emphasis on using natural ingredients. The firm incorporates herbal bioactives to meet the growing demand for safe and effective natural ingredients as well as resonate with customers seeking transparency in their skincare choices. Apart from that, the firm also draws inspiration from traditional skincare remedies, especially Ayurveda. These time-tested formulations have demonstrated their efficacy over generations, allowing the firm to harness the power of nature in a way that feels both familiar and effective. Apart from that, these herbal ingredients are also rich in therapeutic properties that address various skin concerns, such as inflammation, aging, and pigmentation issues. "We generally use a wide range of plant extracts, including Barberry extract, Alpha Arbutin, Morus Alba, Mirifica, and so on, in our products. These ingredients are natural and harmless and enhance the overall product effectiveness while providing comprehensive solutions that are hard to replicate and hard to replicate with synthetic alternatives”, explains Mansur.

Stringent Quality Checks to Ensure Product Quality

Origo has a no-compromise policy when it comes to prioritizing the safety and effectiveness of its products. Each of the ingredients is carefully selected after rigorous R&D and quality checks. Each product goes through a series of stringent clinical testing procedures to ensure its efficacy and safety. Even the quality check procedures are meticulously designed, ensuring each step of the production guarantees consistency and purity. Additionally, the firm actively seeks consumer feedback to consistently refine its offerings and enhance customer satisfaction.

Origo also follows a strict evaluation procedure to assess the sustainability practices and ethical standards followed by its suppliers. To ensure responsible sourcing, the firm prioritizes suppliers with recognized certifications. A lot of emphasis is put on supply chain transparency, which helps the firm monitor the origin of the ingredients. Apart from that, whenever possible, the firm also sources locally to reduce its carbon footprint and support local communities.
                                                  

Navigating The Challenges of Geographical Expansion 

Starting in 2008, Origo has come a long way in terms of overall growth as well as geographical and portfolio expansion. Today, the firm also has a strong market presence internationally across nine countries, including India, Oman, UAE, Kuwait, Africa, Russia, Mauritius, and so on. While it was Mansur's long-held dream to venture internationally, the road to success has been filled with various challenges. One of the primary challenges was navigating through various regulatory compliances and standards across different countries, which can be extremely complex. The firm mitigated the issue by investing in local regulatory expertise.

Apart from that, Origo also ventured into market understanding, which helped the firm with valuable insight into consumer preferences and cultural differences in those markets. Another major expansion challenge was complicated logistics and supply chains across those countries. To address this, the firm focussed on building robust partnerships with local distributors and optimizing the supply chain for efficacy and reliability. Even adjusting pricing based on economic conditions and consumer expectations can be challenging. To mitigate that, the firm adopted a flexible pricing strategy to cater to various diverse markets. 

To mitigate the issue of finding the right talents across those countries, the firm started investing in local hiring and training programs to build a knowledgeable team that understands the market dynamics. Mansur also shares Origo's successful journey in Oman, where the firm made use of high-quality local ingredients, such as date seed oil, camel milk, frankincense oil, and so on, to produce world-class skincare products. Origo is one of the first companies to have a factory in Oman for producing skincare products using its own raw materials. 

Future Roadmap

Coming to the future roadmap, for the next five years, Origo has a clear vision to focus on product innovation, market expansion, and sustainability. The firm also aims to continue pioneering the cosmeceutical sector by developing advanced formulations that harness the latest scientific research and innovative ingredients. The firm is also working on introducing neurocosmetics in India. When it comes to global expansion, the firm has clear plans to broaden its presence in key international markets, especially in the Middle East, Africa, and Southeast Asia. This involves not only launching products but also tailoring its offerings to meet local preferences and regulations. “Sustainability commitment remains at the core of our strategy. We aim to enhance our sourcing practices by prioritizing sustainable, ethically sourced ingredients, reducing our carbon footprint. By focusing on these goals, Origo aspires to not only lead in product innovation and market presence but also to be a responsible player in the cosmetics industry, contributing positivity to both consumers and the planet”, Mansur signs off.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2026 India Pharma Outlook. All Rights Reserved.